Press Releases News

Australian University Looks to Growing Chinese Market to Launch Global Luxury Management Degree in Dubai

australian university looks to growing chinese market to launch global luxury management degree in dubai
DUBAI, United Arab Emirates--(BUSINESS WIRE)--Australian University looks to growing Chinese market to launch global luxury management degree in Dubai
Business Wire - Published

Vitamix Blender Sales & Deals for December 2019: Vitamix 5200, A3500 & 7500 Blender Deals Listed by Retail Egg

vitamix blender sales & deals for december 2019: vitamix 5200, a3500 & 7500 blender deals listed by retail egg
BOSTON--(BUSINESS WIRE)--Money saving experts have found the best Vitamix deals for December, including Vitamix 7500, A3500 & 5200 blender deals
Business Wire - Published

World's Top 5 DJanes Win 'Queen of Mashups' Global Title for 2019

world's top 5 djanes win 'queen of mashups' global title for 2019
· Both the winners were judged by the jury as the joint-winners for their unique compositions at the console   · Social media award was won by DJ Natalia Moon of Australia and DJ Jericha from..
NewsVoir - Published

Wealth Clinic Expects Rs. 100 Crore Sales During Property Parade

*Wealth Clinic*, one of the leading real estate consultancies today announced that the Company is expecting an overwhelming response of buyers during Property Parade, which is one of its kind of event,..
NewsVoir - Published

Mastering High Net Worth with Transamerica Life Bermuda

mastering high net worth with transamerica life bermuda
New initiative to support financial advisors and key business partners in better serving their High Net Worth (HNW) customers HONG KONG, Dec. 9, 2019 /PRNewswire/ -- Transamerica Life (Bermuda)..
PR Newswire Asia - Published

Borderless Access Pivots its Business Focus by Adding Next-Gen Tools and Holistic Consumer Understanding as it Completes 11 Years

borderless access pivots its business focus by adding next-gen tools and holistic consumer understanding as it completes 11 years
BANGALORE, India, Dec. 9, 2019 /PRNewswire/ -- The initial 10 years witnessed Borderless Access evolve from an online & mobile panel company into one of the leading global digital market research..
PR Newswire Asia - Published

ANANDA appoints ANGEL REAL ESTATE to manage sales operations of Ideo brand in global markets

ananda appoints angel real estate to manage sales operations of ideo brand in global markets
BANGKOK, Dec. 9, 2019 /PRNewswire/ -- Ananda Development Public Company Limited (ANAN), leading real estate developer in Thailand, with positioning of "Urban Living Solutions", appoints Angel Real..
PR Newswire Asia - Published signs on Century 21, affirming its position as Singapore's Smartest Property Portal signs on century 21, affirming its position as singapore's smartest property portal
Ad-free property portal- boasts over 260,000 search keywords and more than 70,000,000 geodata points, which includes nearby amenities and facilities, allowing agents to list with greater ease..
PR Newswire Asia - Published

Wemade Tree Announces Blockchain Platform 'WEMIX Network' and Game Lineup

wemade tree announces blockchain platform 'wemix network' and game lineup
SEOUL, South Korea, Dec. 9, 2019 /PRNewswire/ -- On November 22, Wemade Tree, a subsidiary company of Wemade Co., Ltd., as its flagship blockchain gaming services arm, held a press conference..
PR Newswire Asia - Published

Buzzvil Hits 10 million Monthly Active Users

SEOUL, South Korea, Dec. 9, 2019 /PRNewswire/ -- Buzzvil, a global leading provider of rewarded ads platform and a member company of the Born2Global Centre, today announced that the company hit 10.5..
PR Newswire Asia - Published

BankerBay is now Aurigin

*- The Platform for Deal Origination* NEW YORK, Dec. 9, 2019 /PRNewswire/ -- BankerBay, the world's largest private deal origination platform, announced today that it has rebranded to Aurigin,..
PR Newswire Asia - Published

InterContinental® Hotels & Resorts Launches InterContinental ICons, Inviting Travellers to Rediscover What Makes a City Truly Fascinating

intercontinental® hotels & resorts launches intercontinental icons, inviting travellers to rediscover what makes a city truly fascinating
CANNES, France, Dec. 9, 2019 /PRNewswire/ -- InterContinental® Hotels & Resorts, the world's largest luxury hotel brand, today launches *InterContinental ICons*, offering travellers a fresh look at..
PR Newswire Asia - Published

Carrier Wins Strategic HVAC Contract for Tim Hortons Chain of Coffee Houses in China

carrier wins strategic hvac contract for tim hortons chain of coffee houses in china
SHANGHAI, Dec. 9, 2019 /PRNewswire/ -- Carrier, a leading global provider of innovative heating, ventilating and air conditioning (HVAC), refrigeration, fire, security and building automation..
PR Newswire Asia - Published

Rocket Pharmaceuticals Presents Promising Preliminary Results from Phase 1 Trial of Commercial-Grade RP-L102 “Process B” for Fanconi Anemia at 61st American Society of Hematology Annual Meeting

NEW YORK--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood..
Business Wire - Published

Aurora Bio, Inc Announces Clinical Data on Lead Program, AUR01, a Novel Systemic Amyloidosis Imaging Tracer, at the Upcoming 61st American Society of Hematology Annual Meeting and Exposition

ORLANDO, Fla.--(BUSINESS WIRE)--Aurora Bio, Inc today announced data for the company’s novel PET radiotracer, AUR01, in development for systemic amyloidosis, was presented by Dr...
Business Wire - Published

Trade Finance Scale-up Stenn Doubles Credit Capacity

LONDON, Dec. 9, 2019 /PRNewswire/ -- UK-based Stenn, a leading provider of cross-border trade finance, has closed a significant upsizing to its asset-backed financing programme. Stenn has now..
PR Newswire Asia - Published

Bristol-Myers Squibb Announces Studies Evaluating liso-cel in Multiple Additional Patient Populations, Site of Care and Disease Areas Presented at American Society of Hematology (ASH) Annual Meeting

bristol-myers squibb announces studies evaluating liso-cel in multiple additional patient populations, site of care and disease areas presented at american society of hematology (ash) annual meeting
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY--Studies Evaluating Liso-Cel in Multiple Additional Patient Populations, Site of Care and Disease Areas Presented at American Society of Hematology
Business Wire - Published

Company Profile for Jasper Therapeutics, Inc

company profile for jasper therapeutics, inc
--(BUSINESS WIRE)--Jasper Therapeutics is a biotechnology company focused on enabling safer conditioning agents and therapeutics to allow for expanded use of curative hematopoietic stem cell..
Business Wire - Published

InterGen Data, Inc. Announces a Major Enhancement to its Chronic Illness Prediction Capabilities

intergen data, inc. announces a major enhancement to its chronic illness prediction capabilities
PLANO, Texas--(BUSINESS WIRE)-- #Compliance--InterGen Data, Inc. (InterGen Data), an AI based ML-driven data technology provider has increased their predictive capabilities by over 1300%. Today’s..
Business Wire - Published

ZEN LOSS ALERT: ROSEN LAW FIRM Reminds Zendesk, Inc. Investors of Important December 23rd Deadline in Securities Class Action - ZEN

zen loss alert: rosen law firm reminds zendesk, inc. investors of important december 23rd deadline in securities class action - zen
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zendesk, Inc. (NYSE: ZEN) between February 6, 2019 and October 1, 2019 (the..
Business Wire - Published

Cerevel Therapeutics Announces Phase 1 Results for CVL-865, a Novel α2/3/5-subtype GABAA Positive Allosteric Modulator in Development to Treat Epilepsy

cerevel therapeutics announces phase 1 results for cvl-865, a novel α2/3/5-subtype gabaa positive allosteric modulator in development to treat epilepsy
BOSTON--(BUSINESS WIRE)--Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced today results of a Phase 1 dose-escalation clinical..
Business Wire - Published

Stoke Therapeutics Presents Preclinical Data on the Biodistribution, Target Engagement and Safety of STK-001 in Non-Human Primates That Support the Planned Clinical Development of STK-001 for the Treatment of Dravet Syndrome

stoke therapeutics presents preclinical data on the biodistribution, target engagement and safety of stk-001 in non-human primates that support the planned clinical development of stk-001 for the treatment of dravet syndrome
BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company pioneering a new way to treat the underlying cause of severe genetic diseases by precisely upregulating..
Business Wire - Published

Syros Presents on Identification of Novel Fetal Hemoglobin Repressor as Part of Broader Drug Discovery Program in Sickle Cell Disease at 61st Annual ASH Meeting

syros presents on identification of novel fetal hemoglobin repressor as part of broader drug discovery program in sickle cell disease at 61st annual ash meeting
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced that it has discovered and..
Business Wire - Published

Beam Therapeutics Presents Preclinical Data for Complementary Base Editing Approaches for Hemoglobinopathies at ASH 2019

beam therapeutics presents preclinical data for complementary base editing approaches for hemoglobinopathies at ash 2019
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Beam Therapeutics, a biotechnology company developing precision genetic medicines through base editing, today announced new preclinical data for the company’s..
Business Wire - Published

GE Healthcare Life Sciences pairs up with Advanced Solutions Life Sciences to create new opportunities for regenerative tissue manufacturing

ge healthcare life sciences pairs up with advanced solutions life sciences to create new opportunities for regenerative tissue manufacturing
MARLBOROUGH, Mass. & LOUISVILLE, Ky.--(BUSINESS WIRE)-- #biofabrication--GE Healthcare Life Sciences unveils 3D bioprinting partnership with Advanced Solutions for regenerative tissue manufacturing
Business Wire - Published

MetLife Named Life Insurance Company of the Year

metlife named life insurance company of the year
DUBAI, United Arab Emirates--(BUSINESS WIRE)--MetLife was named Life Insurance Company of the Year at the 2019 Middle East Insurance Industry Awards, organized by Middle East Insurance Review
Business Wire - Published

New Data Demonstrate the Continued Clinical Benefit of Fixed-duration, Chemotherapy-free Venclexta-based Treatments in Chronic Lymphocytic Leukemia

new data demonstrate the continued clinical benefit of fixed-duration, chemotherapy-free venclexta-based treatments in chronic lymphocytic leukemia
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced updated data from two pivotal Phase III Venclexta® (venetoclax)..
Business Wire - Published

Comporium Celebrates 125 Years of Service to Customers

ROCK HILL, S.C.--(BUSINESS WIRE)-- #comporiumiscommunity--Comporium, a communications company based in Rock Hill, SC turns 125 on December 10th.
Business Wire - Published

Unlearn.AI Announces Results Generated from First-of-its-Kind Machine Learning Platform to Accelerate Alzheimer’s Drug Development announces results generated from first-of-its-kind machine learning platform to accelerate alzheimer’s drug development
SAN FRANCISCO--(BUSINESS WIRE)--Unlearn.AI announces results generated from first-of-its-kind machine learning platform to accelerate Alzheimer's drug development.
Business Wire - Published

iQIYI Scream Night 2020 Sparks the Year's Entertainment Highlights

iqiyi scream night 2020 sparks the year's entertainment highlights
BEIJING, Dec. 8, 2019 /PRNewswire/ -- iQIYI, Inc. (NASDAQ: IQ) ("iQIYI" or the "Company"), an innovative market-leading online entertainment service in China, held its annual signature iQIYI Scream..
PR Newswire Asia - Published

MaaT Pharma Announces the Presentation of Positive Data with Its Lead Microbiome Biotherapeutic in Intestinal-Predominant Acute Graft-versus-Host-Disease at the ASH 2019 Annual Meeting

maat pharma announces the presentation of positive data with its lead microbiome biotherapeutic in intestinal-predominant acute graft-versus-host-disease at the ash 2019 annual meeting
LYON, France--(BUSINESS WIRE)--MaaT Pharma announced today that leading hemato-oncological experts presented clinical data on the compassionate use of MaaT Pharma’s lead full-ecosystem microbiome..
Business Wire - Published

First Clinical Data with MGTA-145 Show Single-Day Dosing and Collection of Robust Numbers of High-Quality Stem Cells in Healthy Volunteers

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of immune reset to more patients,..
Business Wire - Published

Findings Released from Real-World Data Analysis of Eliquis (apixaban) for the Treatment of Venous Thromboembolism in Patients with Active Cancer

findings released from real-world data analysis of eliquis (apixaban) for the treatment of venous thromboembolism in patients with active cancer
PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Findings Released from Real-World Data Analysis of Eliquis (apixaban) for the Treatment of Venous Thromboembolism in Patients with Active Cancer
Business Wire - Published

Aleta Biotherapeutics Presents In Vivo Results of a Novel Therapeutic Designed to Reactivate CAR T Cells in Patients Who Relapse After CAR T Therapy

aleta biotherapeutics presents in vivo results of a novel therapeutic designed to reactivate car t cells in patients who relapse after car t therapy
NATICK, Mass.--(BUSINESS WIRE)--Aleta Biotherapeutics today presented in vitro and in vivo results of novel CD19-anti-CD20 bridging protein technology at ASH 2019.
Business Wire - Published

Kite Announces Long-term Data From ZUMA-1 Showing Approximately Half of Refractory Large B-cell Lymphoma Patients Were Alive Three Years After Yescarta Treatment

kite announces long-term data from zuma-1 showing approximately half of refractory large b-cell lymphoma patients were alive three years after yescarta treatment
ORLANDO, Fla.--(BUSINESS WIRE)--Kite, a Gilead Company (Nasdaq: GILD), today announced new data from the ZUMA-1 trial of Yescarta® (axicabtagene ciloleucel) in adult patients with refractory large..
Business Wire - Published

Nihon Kohden Donates to Epilepsy Research for 11th Consecutive Year

nihon kohden donates to epilepsy research for 11th consecutive year
IRVINE, Calif.--(BUSINESS WIRE)--Nihon Kohden donates to the American Epilepsy Society’s (AES) clinical and basic research fellowships for the 11th consecutive year
Business Wire - Published

Seattle Genetics Announces Updated Data of ADCETRIS® (Brentuximab Vedotin) in Combination with OPDIVO® (Nivolumab) in Frontline and Relapsed or Refractory Hodgkin Lymphoma at ASH Annual Meeting

seattle genetics announces updated data of adcetris® (brentuximab vedotin) in combination with opdivo® (nivolumab) in frontline and relapsed or refractory hodgkin lymphoma at ash annual meeting
BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) today announced updated and long-term follow-up analyses from two clinical trials evaluating ADCETRIS (brentuximab vedotin) and..
Business Wire - Published

Bristol-Myers Squibb Announces Liso-Cel Met Primary and Secondary Endpoints in TRANSCEND NHL 001 Study

bristol-myers squibb announces liso-cel met primary and secondary endpoints in transcend nhl 001 study
Business Wire - Published

bluebird bio Presents New Data from Ongoing Phase 1/2 HGB-206 Study of LentiGlobin™ Gene Therapy for Sickle Cell Disease (SCD) at 61st ASH Annual Meeting and Exposition

bluebird bio presents new data from ongoing phase 1/2 hgb-206 study of lentiglobin™ gene therapy for sickle cell disease (scd) at 61st ash annual meeting and exposition
CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio Presents New Data from Ongoing Phase 1/2 HGB-206 Study of LentiGlobin™ Gene Therapy for Sickle Cell Disease (SCD) at ASH Annual Meeting
Business Wire - Published

Cortexyme Announces Presentation of Data Revealing Link Between Bacterial Pathogen and Genetic Risk for Alzheimer’s Disease

cortexyme announces presentation of data revealing link between bacterial pathogen and genetic risk for alzheimer’s disease
SAN DIEGO & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cortexyme, Inc. (Nasdaq: CRTX) today announced the presentation of new data supporting the on-target activity of COR388, its lead..
Business Wire - Published

Stoke Therapeutics Presents Preclinical Data From Studies of STK-001 That Showed Improvements in Survival and Reductions in Seizure Frequency in a Mouse Model of Dravet Syndrome

stoke therapeutics presents preclinical data from studies of stk-001 that showed improvements in survival and reductions in seizure frequency in a mouse model of dravet syndrome
BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq:STOK), a biotechnology company pioneering a new way to treat the underlying cause of severe genetic diseases by precisely upregulating..
Business Wire - Published

Imbruvica®▼(ibrutinib) Combination Therapy Data From Two Studies and Long-Term Integrated Analysis Presented at ASH 2019 Show Efficacy and Safety in First-Line Treatment of Chronic Lymphocytic Leukaemia

imbruvica®▼(ibrutinib) combination therapy data from two studies and long-term integrated analysis presented at ash 2019 show efficacy and safety in first-line treatment of chronic lymphocytic leukaemia
BEERSE, Belgium--(BUSINESS WIRE)--The Janssen Pharmaceutical Companies of Johnson & Johnson today announced combination data from two studies and a long-term integrated analysis evaluating the use of..
Business Wire - Published

Janssen Presents Initial Results for BCMA CAR-T Therapy JNJ-4528 Showing Early, Deep and High Responses in the Treatment of Relapsed or Refractory Multiple Myeloma

janssen presents initial results for bcma car-t therapy jnj-4528 showing early, deep and high responses in the treatment of relapsed or refractory multiple myeloma
BEERSE, Belgium--(BUSINESS WIRE)--The Janssen Pharmaceutical Companies of Johnson & Johnson announced today initial results from the Phase 1b/2 CARTITUDE-1 study (NCT03548207) evaluating the efficacy..
Business Wire - Published

Epizyme Presents Updated Phase 2 Data at the 2019 ASH Annual Meeting Supporting Planned Tazemetostat NDA Submission for Follicular Lymphoma

epizyme presents updated phase 2 data at the 2019 ash annual meeting supporting planned tazemetostat nda submission for follicular lymphoma
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme Presents Updated Phase 2 Data at the 2019 ASH Annual Meeting Supporting Planned Tazemetostat NDA Submission for Follicular Lymphoma
Business Wire - Published

Takeda to Present Results from the Phase 3 TOURMALINE-AL1 Trial of NINLARO in Patients with Amyloidosis

takeda to present results from the phase 3 tourmaline-al1 trial of ninlaro in patients with amyloidosis
CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced that results of the TOURMALINE-AL1 trial will be presented during an oral..
Business Wire - Published

ALX Oncology Presents Initial Data from the ALX148 Clinical Trial Non-Hodgkin Lymphoma Combination Cohort at the 61st American Society of Hematology (ASH)

alx oncology presents initial data from the alx148 clinical trial non-hodgkin lymphoma combination cohort at the 61st american society of hematology (ash)
DUBLIN, Ireland & BURLINGAME, Calif.--(BUSINESS WIRE)--ALX Oncology today announced new results from the hematological portion of the ALX148 Phase 1 program at the 2019 ASH Annual Meeting.
Business Wire - Published

Verastem Oncology Presents Phase 2 PRIMO Study Data Evaluating Duvelisib in Relapsed or Refractory Peripheral T-Cell Lymphoma at the American Society of Hematology 2019 Annual Meeting

BOSTON--(BUSINESS WIRE)--Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), a biopharmaceutical company focused on developing and commercializing medicines seeking to improve the survival..
Business Wire - Published

Sangamo and Pfizer Announce Updated Phase 1/2 Results Showing Sustained Increased Factor VIII Activity Through 44 Weeks Following SB-525 Gene Therapy Treatment

sangamo and pfizer announce updated phase 1/2 results showing sustained increased factor viii activity through 44 weeks following sb-525 gene therapy treatment
BRISBANE, Calif. & NEW YORK--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, and Pfizer, Inc. (NYSE: PFE), today announced updated follow-up results from the..
Business Wire - Published

Genentech Announces New Data on Novel Cd20-cd3 Bispecific Cancer Immunotherapies in People With Difficult-to-Treat Lymphomas

genentech announces new data on novel cd20-cd3 bispecific cancer immunotherapies in people with difficult-to-treat lymphomas
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced new data on two investigational CD20-CD3 T-cell engaging bispecific..
Business Wire - Published

ALLPCB Accepted the Interview about "Domestic Products Go Global", Sharing Strategies for Non-Standard Industrial Products to Expand Global Market.

allpcb accepted the interview about domestic products go global, sharing strategies for non-standard industrial products to expand global market.
HANGZHOU, China, Dec. 7, 2019 /PRNewswire/ -- On November 14^th 2019, Mr. Zhou Bangbing, chairman of ALLPCB, accepted an exclusive interview on "*Domestic Products Go Global*". The interview is..
PR Newswire Asia - Published

You Might Like

 Page 1  âŚŞ 
Environmentally friendly: newsR is hosted on servers powered solely by renewable energy
© 2019 newsR Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest